zoledronic acid has been researched along with Genital Neoplasms, Female in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banys, M; Beck, V; Fehm, T; Hairass, M; Krimmel, M; Lipp, HP; Reinert, S; Solomayer, EF; Wallwiener, D | 1 |
1 other study(ies) available for zoledronic acid and Genital Neoplasms, Female
| Article | Year |
|---|---|
Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Imidazoles; Incidence; Jaw; Middle Aged; Osteonecrosis; Risk Factors; Zoledronic Acid | 2009 |